Shimazaki Atsushi

Nakamura Kenichi, Fujimoto Tomokazu, Okada Miho, Maki Kentaro, Shimazaki Atsushi, Kato Masatomo et al.

Rabbit studies showed SIBS and silicone glaucoma drainage device materials were more biostable and caused less tissue reactivity than GACLC, suggesting better clinical safety.

Fujimoto Tomokazu, Nakashima Kei-Ichi, Watanabe-Kitamura Fumika, Watanabe Takahiro, Nakamura Kenichi, Maki Kentaro et al.

This rabbit study found MicroShunt insertion lowered IOP similarly to trabeculectomy, suggesting comparable efficacy for glaucoma treatment.

Kirihara Tomoko, Taniguchi Takazumi, Yamamura Kenzo, Iwamura Ryo, Yoneda Kenji, Odani-Kawabata Noriko et al.

Omidenepag isopropyl is a prodrug that converts to a selective EP2 receptor agonist, omidenepag, in the eye. It significantly lowers intraocular pressure in animals, offering a new once-daily glaucoma treatment.